Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp on $17.5 million Secondary Public Offering for Ampio Pharmaceuticals, Inc.
NEW YORK, July 12, 2012 (GLOBE NEWSWIRE) — New York- based securities law firm, Sichenzia Ross Friedman Ference LLP announced that it has represented Aegis Capital Corp and Fordham Financial Management, Inc.as co- managing underwriters in a $17.5 million secondary public offering for Ampio Pharmaceuticals, Inc. (“AMPE” NASDAQ). The underwriting was pursuant to a prospectus supplement to an effective S-3 registration statement. The offering consisted of 5,307,710 shares of common stock at an offering price of $3.25 per share. The Sichenzia Ross team was led by partners Gregory Sichenzia and Marcelle Balcombe and associate Jeff Cahlon.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Attorneys Selected for Inclusion on 2019 Super Lawyers Lists - October 16, 2019
- Sichenzia Ross Ference LLP to Join Client Relmada Therapeutics, Inc. at Nasdaq Opening Bell Ringing - October 15, 2019
- Sichenzia Ross Ference LLP Congratulates Relmada Therapeutics, Inc., on NASDAQ Uplisting - October 10, 2019